Task force weighs in on ABI use for PAD screening

09/4/2013 | HealthDay News

It is still unclear whether the use of ankle brachial index in peripheral artery disease screening and cardiovascular risk assessment would be beneficial to people with no symptoms, according to recommendations by the U.S. Preventive Services Task Force. One expert lauded the recommendation, while another stated that the task force's stance toward the procedure conflicts those of other organizations' guidelines. The recommendations were published in the Annals of Internal Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD